Search for: "LILLI JOHNSON" Results 21 - 40 of 243
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Dec 2013, 1:27 am
* Despite its apparent logic, Eli Lilly's application was logically incoherent. [read post]
29 Sep 2009, 9:41 am
Here's a list of some important stories we've been tracking.Boston Globe article probing the financial ties between Massachusetts doctors and Eli Lilly, a large drug manufacturer. [read post]
3 May 2013, 4:10 am by Howard Friedman
Plaintiff Lilli Johnson, a Catholic, is a 50% stockholder of the Ohio company that manufactures air brake components; her 7 children own the remaining 50%. [read post]
10 Jan 2010, 3:53 pm by Levin & Perconti
One such kickback was their recommendation of Johnson & Johnson's Risperdal antipsychotic to nursing homes. [read post]
15 Jun 2009, 1:01 pm
., has construed the Lilly Ledbetter Fair Pay Act as extending workers' time to sue only for claims based on pay bias. [read post]
8 Aug 2011, 12:53 pm by info@thomasjhenrylaw.com
A South Carolina judge has ordered a Johnson & Johnson subsidiary to pay $327 million in fines for deceptive marketing of their anti-psychotic drug, Risperdal. [read post]
8 Apr 2008, 12:25 am
The NYT has posted an insightful article about the realities of preemption, and specifically Johnson & Johnson and its Ortho Evra Patch. [read post]
22 Jan 2010, 5:26 am by Lebowitz & Mzhen
Eli Lilly pleaded guilty to a misdemeanor last January in a nearly $1.5 billion settlement of criminal and civil charges that the pharmaceutical company had marketed Zyprexa, the antipsychotic drug for the treatment of dementia with elderly people. [read post]
2 May 2011, 4:30 am by Laura Simons
., a Johnson & Johnson subsidiary, should pay the state for what the jury found to be deceptive marketing by the company of its antipsychotic drug Risperdal. [read post]
17 Feb 2018, 7:31 am
  This rule provides that there can be no patent infringement by equivalence if the description discloses several possibilities as to how a technical effect can be achieved, but only one of those are included within the claims of the Patent (similar to the Johnson & Johnston disclosure-dedication rule in the US). [read post]
13 Apr 2012, 7:19 am by admin
That same year, Eli Lilly pleaded guilty to criminal conduct involving its marketing of the antipsychotic drug Zyprexa and agreed to pay $1.4 billion in fines. [read post]
16 Apr 2014, 9:05 pm by Walter Olson
Academics have underestimated sensitivity of medical system to liability pressures [Michael Frakes, SSRN via TortsProf] “Nobody has gone out and bought a new home” — Mark Lanier talks down his verdict knocking $9 billion out of Takeda and Lilly after two hours of deliberation by a Lafayette, La. jury [Reuters] Japanese drugmaker says it had won three previous trials [ABA Journal] Nursing home in living-up-to-its-name town of West Babylon sued over hiring male… [read post]
25 Aug 2015, 7:10 am by Noble McIntyre
Other inhibitors in this class include Farxiga and Xigduo by AstraZeneca, Jardiance by Lilly, and Glyxambi by Boehringer Ingelheim. [read post]
9 Nov 2010, 4:30 am by Laura Simons
A Louisiana jury in mid-October issued a $257.7 million verdict against Janssen Pharmaceutica, Inc. and its parent company, Johnson & Johnson, finding that the drugmaker misled Louisiana doctors about possible side effects of its antipsychotic drug Risperdal. [read post]
13 Apr 2014, 2:40 pm
The court also ordered Takeda’s U.S. partner, Eli Lilly, which marketed the drug in this country, to pay $3 billion. [read post]